Gene · 3732
Papers4,224
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,224
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Defining the Skeletal Myogenic Lineage in Human Pluripotent Stem Cell-Derived Teratomas. | Cells | 2022 | 35563894 | PubTator, text mining | PubMed |
| Exosomal miRNAs as a Promising Source of Biomarkers in Colorectal Cancer Progression. | Int J Mol Sci | 2022 | 35563246 | PubTator, text mining | PubMed |
| CD82 palmitoylation site mutations at Cys5+Cys74 affect EGFR internalization and metabolism through recycling pathway. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35538033 | Swiss-Prot, curated | PubMed |
| GM2/GM3 controls the organizational status of CD82/Met microdomains: further studies in GM2/GM3 complexation. | Glycoconj J | 2022 | 35536494 | PubTator, text mining | PubMed |
| Tumor-derived extracellular vesicles: Potential tool for cancer diagnosis, prognosis, and therapy. | Saudi J Biol Sci | 2022 | 35531155 | PubTator, text mining | PubMed |
| A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin. | Transl Neurodegener | 2022 | 35527262 | PubTator, text mining | PubMed |
| Tetraspanin 7 promotes osteosarcoma cell invasion and metastasis by inducing EMT and activating the FAK-Src-Ras-ERK1/2 signaling pathway. | Cancer Cell Int | 2022 | 35524311 | PubTator, text mining | PubMed |
| Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma. | Mol Ther Oncolytics | 2022 | 35506150 | PubTator, text mining | PubMed |
| Strategies for Glycoengineering Therapeutic Proteins. | Front Chem | 2022 | 35494652 | PubTator, text mining | PubMed |
| SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer. | Front Oncol | 2022 | 35494088 | PubTator, text mining | PubMed |
| Ex Vivo Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside. | Front Immunol | 2022 | 35493497 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Transforming Growth Factor β Signaling in Cancer. | Front Cell Dev Biol | 2022 | 35493080 | PubTator, text mining | PubMed |
| Prognostic Biomarker NUMB Is Inhibited by Breast Cancer Cell Exosomes to Promote Breast Cancer Progression. | J Immunol Res | 2022 | 35478938 | PubTator, text mining | PubMed |
| Migrasomes: From Biogenesis, Release, Uptake, Rupture to Homeostasis and Diseases. | Oxid Med Cell Longev | 2022 | 35464764 | PubTator, text mining | PubMed |
| Analysis of the Challenges of Artificial Intelligence of Things (AIoT) for the Smart Supply Chain (Case Study: FMCG Industries). | Sensors (Basel) | 2022 | 35458916 | PubTator, text mining | PubMed |
| Specific Interaction of DARPin with HIV-1 CANTD Disturbs the Distribution of Gag, RNA Packaging, and Tetraspanin Remodelling in the Membrane. | Viruses | 2022 | 35458554 | PubTator, text mining | PubMed |
| High Sensitivity and Specificity of Dormitory-Level Wastewater Surveillance for COVID-19 during Fall Semester 2020 at Syracuse University, New York. | Int J Environ Res Public Health | 2022 | 35457720 | PubTator, text mining | PubMed |
| Cancer-Derived Extracellular Vesicles: Their Role in Sarcoma. | Life (Basel) | 2022 | 35454972 | PubTator, text mining | PubMed |
| Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to Overcome. | Cancers (Basel) | 2022 | 35454937 | PubTator, text mining | PubMed |
| A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers. | Cancer Cell | 2022 | 35452604 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3732/papers?page=43